New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in England

New direct‐acting antivirals have the potential to transform the hepatitis C (HCV) treatment landscape, with rates of sustained viral response in excess of 90%. As these new agents are expensive, an important question is whether to focus on minimizing the consequences of severe liver disease, or red...

Descripción completa

Detalles Bibliográficos
Autores principales: Harris, R. J., Martin, N. K., Rand, E., Mandal, S., Mutimer, D., Vickerman, P., Ramsay, M. E., De Angelis, D., Hickman, M., Harris, H.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982023/
https://www.ncbi.nlm.nih.gov/pubmed/27025238
http://dx.doi.org/10.1111/jvh.12529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982023/
https://www.ncbi.nlm.nih.gov/pubmed/27025238
http://dx.doi.org/10.1111/jvh.12529

Ejemplares similares